SERUM DRUG CONCENTRATIONS IN CLINICAL PERSPECTIVE

被引：23

作者：

KOCHWESER, J

机构：

来源：

THERAPEUTIC DRUG MONITORING | 1981年 / 3卷 / 01期

关键词：

D O I：

10.1097/00007691-198109000-00002

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

收藏

页码：3 / 16

页数：14

相关论文

共 54 条

[1] SERUM LEVEL MONITORING AND CLINICAL PHARMACOKINETICS OF LITHIUM
AMDISEN, A
[J]. CLINICAL PHARMACOKINETICS, 1977, 2 (02) : 73 - 92
[2] AMSTERDAM J, 1980, AM J PSYCHIAT, V137, P653
[3] ARIENS EJ, 1974, CLIN PHARMACOL THER, V16, P155
[4] AZARNOFF DL, 1974, CLIN PHARMACOL THER, V16, P129
[5] WHY MONITOR SERUM LEVELS OF GENTAMICIN
BARZA, M
LAUERMANN, M
[J]. CLINICAL PHARMACOKINETICS, 1978, 3 (03) : 202 - 215
[6] BERNABEI R, 1977, J CARDIOVASC PHARMAC, V2, P319
[7] PHYSICOCHEMICAL AND BIOCHEMICAL ASPECTS OF PHARMACOLOGY
BRODIE, BB
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (07) : 600 - +
[8] SERUM DIGITALIS MEASUREMENTS IN ASSESSMENT OF DIGITALIS RESISTANCE AND SENSITIVITY
BUTLER, VP
LINDENBAUM, J
[J]. AMERICAN JOURNAL OF MEDICINE, 1975, 58 (04) : 460 - 469
[9] PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS
COOPER, TB
[J]. CLINICAL PHARMACOKINETICS, 1978, 3 (01) : 14 - 38
[10] REDUCTION OF DIGOXIN TOXICITY ASSOCIATED WITH MEASUREMENT OF SERUM LEVELS - REPORT FROM BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM
DUHME, DW
GREENBLATT, DJ
KOCHWESE.J
[J]. ANNALS OF INTERNAL MEDICINE, 1974, 80 (04) : 516 - 519

← 1 2 3 4 5 6 →